Objective: Pressure overload induced by pulmonary artery banding (PAB) leads to right ventricular (RV) hypertrophy and cardiomyocyte apoptosis. The present study was performed to investigate whether protein kinase C isozymes (PKC-a, PKC-bI, PKC-bII, PKC-d and PFC-´), calcineurin and the renin-angiotensin system (RAS) contribute to PAB-induced cardiac remodeling. Methods and results: PAB in male Wistar rats for 3 weeks results in enhanced PKC activity (as determined by ELISA assay) in the cytosol and membrane fraction of the hypertrophied RV, which was accompanied by increased expression (as determined by Western blot analysis) of cytosolic PKC-d (172%), PKC-a (149%), and PKC-bI (139%), but not PKC-bII and PKC-´. This differential regulation of cardiac PKC isozymes was limited to the strained ventricle and was not altered in response to chronic angiotensin-converting enzyme inhibition with ramiprilate. Furthermore, no significant changes in the expression of calcineurin a and b subunits were observed in RV pressure overload compared to controls. PAB-induced cardiac apoptosis was determined using Western blot analysis by a significantly increased expression of Bax protein and caspase-3 in the hypertrophied RV, which was diminished to almost control levels by chronic ramiprilate treatment. The myocardial expression of Bcl-2 was not significantly altered in the experimental groups. Conclusion: We have shown for the first time that PAB-induced RV hypertrophy is associated with a differential regulation of cardiac PKC isozymes independent of the RAS and further provide evidence for a pivotal role of the RAS in the development of PAB-induced cardiac apoptosis.
. Introduction
stimuli) of cultured neonatal rat cardiomyocytes leads to the activation of several signaling pathways, including 21 Mechanical overload has been reported to play a pivotal Ca -dependent calmodulin / calcineurin, and diverse prorole in the development of cardiac hypertrophy [1] . In tein kinases such as mitogen-activated protein kinase contrast to the abundance of studies on left ventricular (MAPK) and protein kinase C (PKC) [3, 4] . PKC is a (LV) hypertrophy, only very few investigations have family of growth-promoting isozymes that are known to evaluated the signaling mechanisms which transduce induce cardiac hypertrophy in vivo and in vitro [1] [2] [3] . In hemodynamic stress in right ventricular (RV) hypertrophy.
adult rat heart the PKC isoforms PKC-a, PKC-bI, PKC-d Candidates include the renin angiotensin system (RAS) via and PKC-´predominate, whereas PKC-bII is less abunstimulation of the angiotensin II type 1 receptor (AT1 dant [5] . We have shown previously that LV pressure receptor) or, independent from the RAS, mechanical overload due to banding of the ascending aorta results in a stretch itself [2] . In vitro experiments have shown that differential regulation of PKC isozymes with an upregulastretch (which is one of the most potent hypertrophic tion of PKC-a and PKC-d [6] . Thus, a major focus of the present study was to evaluate whether the expression pattern of cardiac PKC isozymes is altered in response to univentricular PAB-induced RV hypertrophy in a similar PKC isoform specific peptide antibodies from St. Cruz fashion as in LV hypertrophy and whether calcineurin Biotechnology and the enhanced chemiluminescence might play a pivotal role in this remodeling process.
(ECL) Western blotting detection reagents from Amersham Controversial data exist concerning the contribution of the International. Ramiprilate was kindly provided by Aventis local RAS in different experimental models of pressurePharmaceuticals, all other reagents were of analytical overload RV hypertrophy. Whereas RV hypertrophy ingrade obtained from Sigma. duced by chronic hypoxia or monocrotaline (MCT) administration is associated with an activation of the local 2 .2. Procedures RAS [7] and can be attenuated by angiotensin-converting enzyme inhibitors (ACE inhibitors) or AT1 receptor an-2 .2.1. Banding of the main pulmonary artery tagonists [8, 9] , recent studies have shown that the RAS All animal procedures conformed to the Guide for the and its effector peptide angiotensin II (ANG II) are not
Care and Use of Laboratory Animals (National Institutes crucially involved in the development of RV hypertrophy of Health, 1996) and were approved by the local ethics induced by pulmonary artery banding (PAB) [10, 11] .
committee. RV hypertrophy was induced by banding of the These data imply that mechanical overload itself rather main pulmonary artery using sterile tantalum hemostatic than the RAS may cause RV hypertrophy due to PAB, and clips (Edward Weck, Research Triangle Park, NC, USA) as that chronic hypoxia or MCT models may be confounded previously reported [16] . Sham-operated animals underby additional factors such as tissue hypoxia or chronic went the same surgical procedure without insertion of the inflammation. Clinically, ACE inhibitors and AT1 receptor clip. Animals were separated into four groups: (1) shamantagonists are essential for the treatment of LV hyperoperated animals with saline administration (n512), (2) trophy and failure, but have not been established in the rats subjected to pulmonary artery banding (PAB) with therapy of right ventricular hypertrophy. Therefore, we saline administration (n512), (3) sham-operated rats with investigated the influence of chronic ACE inhibition with ramiprilate administration (n512), and (4) rats subjected ramiprilate on PAB-induced RV hypertrophy as well as on to PAB with ramiprilate administration (n512). Ramiprithe expression of PKC isozymes and calcineurin as polate was given twice daily by intraperitoneal injection (20 tential mediators involved in the molecular signaling mg/kg3d), starting 1 day before intervention [17] . Hemoresponsible for RV myocardial growth.
dynamic and biochemical data were obtained 3 weeks after Aside from its growth-promoting properties, PKC is also the operation. To determine the enddiastolic and systolic known to play a pivotal role in the regulation of cardiac pressure in the left and right ventricle (LVEDP, LVSP, apoptosis [12] , which has been demonstrated to occur in RVEDP, RVSP) the chest was opened and the values were the heart during aging [13] and in cardiac hypertrophy measured using a 23 gauge needle inserted into the apex of [14] . The relative abundance of proapoptotic (i.e. Bax, the ventricles. The heart and lung were excised and placed caspase-3) and antiapoptotic signaling factors (i.e. Bcl-2) in ice-cold saline. RV was dissected from the LV (plus determines the susceptibility to cell death [15] . Caspase-3 interventricular septum). RV and LV weight as well as the is a cysteine protease and exists as an inactive 32 kD lung wet weight were determined before the organs were precursor (procaspase-3) which is converted into the active shock-frozen in liquid nitrogen. 20 kD fragment upon activation with apoptosis-inducing stimuli. Again, little is known about the apoptosis sig-2 .2.2. PKC enzyme activity and immunoblot analysis of naling cascade in isolated RV hypertrophy.
cardiac PKC isozymes The purpose of the present study was to determine (i) Preparation of the cytosol and membrane fraction was the expression pattern of distinct cardiac PKC isozymes in performed as previously described [18] . PKC activity was the development of PAB-induced RV hypertrophy, (ii) the measured in both fractions of the right and left ventricle expression of the calcineurin a and b subunits and (iii) the using a commercially available ELISA-based assay expression of the apoptosis-regulating proteins Bax (Mobitec, Germany) with a peptide substrate suitable for (proapoptotic), Bcl-2 (antiapoptotic) and caspase-3 as all isoforms as previously described in detail [17, 18] . PKC effector enzymes in the apoptosis signaling pathway. The activity was determined as the maximally stimulated possible role of the RAS with respect to these features of enzyme activity after stimulation with calcium (1.25 mM), the PAB-induced remodeling process was studied after phosphatidylserine (100 mg / ml) and diacylglycerol (20 chronic treatment with the ACE inhibitor ramiprilate. mg / ml). Baseline activity was determined in parallel in the presence of 10 mM EDTA and 10 mM EGTA. For Western blot analysis, aliquots (20 and 40 mg protein) of 2 . Methods the cytosol and the particulate fraction were separated on an 8% SDS-polyacrylamide gel, transferred to nitrocellu-2 .1. Materials lose and the membranes incubated with PKC-subtypespecific polyclonal antibodies (1:1000), washed three times Male Wistar rats (¯180-200 g) were purchased from in 100 ml TBS containing 0.3% Tween 20, incubated at Thomae, Biberach, the PKC ELISA kit from Mobitec, room temperature for 45 min with a peroxidase-linked secondary anti-IgG rabbit antibody (Amersham) and the tional) and the chemiluminescence detection system. A immuncomplex visualized by ECL reaction. X-rays were commercially available antibody (St. Cruz Biotechnology) evaluated by laser densitometry (Ultroscan XL, LKB, was used for immundetection of caspase-3, which recogGermany). To characterize the specificity of the labeled nizes the inactive 32 kD procaspase-3 and the 20 kD bands, aliquots were analysed in the presence of the fragment of active caspase-3. Because procaspase-3 is a antigenic peptide to abolish immunolabeling. Linearity of precursor and has to be proteolytically cleaved to become the detection system was confirmed in preliminary experithe activated protease caspase-3, the caspase-3 / procasments by assaying serial dilutions of cytosolic and mempase-3 ratio was used as an index of caspase-3 activation. brane protein in the range 10-100 mg protein sample loading for all PKC isozymes except PKC-bII. For signifi-2 .2.5. Statistical analysis cant PKC-bII immunolabeling the protein amount per All data were analyzed by ANOVA with post hoc testing sample was three times higher as compared to the other for statistical significance. Data are presented as PKC isozymes. To ensure identical protein loading of the mean6S.E.M. and P,0.05 was considered significant. different lanes, Ponçeau S staining of the blot was performed. The laser densitometric data of the Western blot analysis were corrected for the Ponçeau S staining.
. Results

.2.3. Calcineurin expression
.1. Cardiac hypertrophy and hemodynamic parameters
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Calcineurin is a soluble Ca / calmodulin-regulated enzyme consisting of a catalytic a subunit (61 kD, PAB for 3 weeks significantly increased the RV index by 21 calcineurin A) and a Ca -binding b subunit (18 kD, 72%, RV systolic pressure by 84% and the pulmonary calcineurin B). Western blot analysis using a monoclonal artery gradient (RVSP-PAP) as compared to sham-operated calcineurin a subunit antibody and a monoclonal calcontrols (Table 1) . PAB-induced RV overload was reflected cineurin b subunit antibody (Sigma) was performed to by an enhanced RVEDP, whereas overt signs of RV failure evaluate the expression of both calcineurin subunits in the such as acites were absent. There were no changes in cytosolic fraction. After the standard wash procedure, the LVSP, LVEDP or the LV index, suggesting that LV nitrocellulose membrane was incubated with a peroxidasefunction was not altered by PAB-induced RV hypertrophy. linked secondary anti-mouse IgG and the immuncomplex Furthermore, the RV parameters were not markedly altered visualized by enhanced chemiluminescence reaction.
by chronic treatment with the ACE inhibitor ramiprilate, providing evidence that ramiprilate did not influence RV 2 .2.4. Apoptosis hypertrophy in response to anatomically fixed afterload. The expression of apoptosis-regulating proteins (Bax, Bcl-2) and caspase-3 was determined by Western blot 3 .2. PKC enzyme activity after subcellular fractionation analysis. For immunoblot assay of Bcl-2 and Bax proteins, aliquots of the cytosolic fraction from the left and right PKC activity in the cytosol and membrane fraction of ventricle were separated on a 12% polyacrylamide minigel the right ventricle was significantly increased in the PAB (Bio Rad), transferred to nitrocellulose and the membranes group by 42 and 24% (Table 2 ) compared to sham controls incubated with a rabbit polyclonal Bcl-2 antibody (St. Cruz and was not markedly attenuated in response to chronic Biotechnology) and for Bax immunolabeling with a rabbit treatment with ramiprilate (47 and 20%). In contrast to the polyclonal Bax antibody (Oncogene). After washing, Bclright ventricle, PKC activity in the cytosol and membrane 2-and Bax-bound antibodies were detected by horse radish fraction of the left ventricle was not altered in the peroxidase-conjugated anti-rabbit IgG (Chemicon Internaexperimental groups. To exclude differences in protein recovery during preparation, total PKC activity was meaoperated controls, which additionally was also not insured in the crude homogenate of the heart tissue. As fluenced by chronic ramiprilate treatment. determined for the whole heart, total PKC activity in the hypertrophied RV was significantly enhanced by 30%
Taken together, these data show that the development of (31.664.8 vs. 24 (Fig. 3 , upper induced RV hypertrophy compared to sham controls (Fig.  part) . The statistical analysis of the whole set of experi-1). The density of the immunolabeling for PKC-´(92, 94 ments shows that the expression of calcineurin A and kD) and PKC-bII (80 kD) was unchanged in both groups.
calcineurin B was not markedly changed in the hyperLaser densitometric analysis of the whole set of experitrophied RV in response to PAB as well as in response to ments revealed that PAB results in an increased expression chronic ramiprilate treatment compared to sham-operated of cytosolic PKC-a by 49%, PKC-d by 72% and PKC-bI controls. Additionally, no significant differences in the by 39%. Chronic ACE inhibition with ramiprilate did not immunolabeling of calcineurin A and calcineurin B were alter this differential expression pattern of PKC isozymes observed in LV for the evaluated groups (Fig. 3 , lower in PAB-induced RV hypertrophy. The Western blot analypart). ses of the PKC isozymes in the membrane fraction of the hypertrophied right ventricle are shown in the lower part of 3 .5. Apoptosis in PAB-induced RV hypertrophy Fig. 1 . Similar to the regulation in RV cytosol, immunoblotting of membrane-associated PKC-a and PKC-d was Apoptosis in PAB-induced cardiac hypertrophy was markedly enhanced in the PAB group, which again was not evaluated by Western blot analysis of Bax (proapoptotic), altered in response to ramiprilate. However, the expression Bcl-2 (antiapoptotic) and caspase-3. of the other PKC isoforms (PKC-bII, PKC-´as well as PKC-bI) was unchanged.
.5.1. Expression of Bax and Bcl-2
Representative Bax and Bcl-2 protein immunoblot anal-3 .3.2. Left ventricle yses are demonstrated in the upper part of Fig. 4 . PABRepresentative immunoblot analyses of the PKC isoinduced RV hypertrophy exhibited a 46% increase of Bax forms from the cytosol and membrane fraction of the LV expression compared to sham-operated controls, which are shown in Fig. 2 for all experimental groups in analogy was significantly attenuated by chronic ramiprilate treatto those shown for the RV (see Fig. 1 ). Quantification of ment. Immunolabeling of Bcl-2 failed to detect significant the whole set of experiments by laser densitometry redifferences in the expression between the evaluated vealed that PAB did not significantly alter the expression groups. Accordingly, the Bax / Bcl-2 ratio was significantly pattern of LV cardiac PKC isozymes compared to shamincreased in PAB / saline by 42% compared to sham / saline and by 36% compared to PAB / ramiprilate (lower part of expression of caspase-3 and procaspase-3 in the LV is Fig. 4) . The expression of Bax and Bcl-2 protein in the left demonstrated in the right part of Fig. 5 , showing no ventricle did not show marked changes in any experimensignificant alterations in the expression pattern. tal group (Fig. 4, right panel) .
.5.2. Expression of caspase-/procaspase-3
4 . Discussion The expression of procaspase-3 (32 kD, inactive form) and caspase-3 (20 kD, active form) in the RV and LV was
The present study demonstrates for the first time that determined by Western blot analysis (Fig. 5, upper part) .
PAB-induced RV hypertrophy is associated with enhanced RV hypertrophy due to PAB for 3 weeks was associated total PKC enzyme activity and increased expression of with a significantly increased labeling of caspase-3 protein, PKC-a, PKC-bI and PKC-d, whereas the amount of PKCwhich was diminished by chronic administration of´and PKC-bII was unchanged. The degree of RV hyramiprilate. The expression of procaspase-3 was not alpertrophy as well as the differential expression pattern of tered in the experimental groups. A quantitative analysis of cardiac PKC isozymes in this model of anatomically fixed all experiments is illustrated at the bottom of Fig. 5 as a RV outflow tract obstruction were not significantly inpercentage of caspase-3 (hatched bars) or procaspase-3 fluenced by chronic treatment with the ACE inhibitor (white bars) expression in PAB rats relative to the expresramiprilate. These data are in good agreement with an sion of sham-operated controls and shows a 52% increase earlier study of Zierhut et al., who showed that inhibition in caspase-3 expression in PAB / saline vs. sham / saline. of the RAS in rats did not influence RV hypertrophy in Chronic ACE inhibition with ramiprilate attenuates the response to PAB [16] . Similar results were found by Segar PAB-induced upregulation of caspase-3 to almost control et al. in fetal sheep and by Rouleau et al. in rabbits, who levels, suggesting that the RAS /ANG II system might play demonstrated that PAB-induced RV hypertrophy was not a pivotal role in PAB-induced caspase-3 upregulation. The attenuated by chronic ACE inhibition with captopril or authors report a significant contribution of the RAS to LV that the Ca -regulated phosphatase calcineurin plays a hypertrophic growth due to aortic stenosis [19] or systemic pivotal role in the development of cardiac hypertrophy hypertension [15, 20] , others have questioned a major role [25, 26] , several groups reported controversial results of the RAS in the development of LV hypertrophy due to [25, 27] . It should be pointed out that the above in vivo and pressure overload [21, 22] . The data of the present study in vitro data were predominantly obtained from the left support a limited impact of the RAS on pressure-overload ventricle, which differs in its biochemical and physiologi-RV hypertrophy, which might be explained by the anacal properties from the right ventricle [28] . In contrast to tomically fixed stenosis of the ventricular outflow tract, LV hypertrophy, no data are available on calcineurin leading to a significant increase in ventricular load, which regulation of pressure-overload-induced RV hypertrophy. itself seems to be crucially involved in the development of To our knowledge the present study shows for the first cardiac hypertrophy.
time that the expression of both calcineurin a and b Mechanical overload has been reported to represent one subunits was not changed in PAB-induced RV hyperof the most potent stimuli of cardiomyocyte hypertrophy, trophy, suggesting that calcineurin is not involved in PABleading to increased protein synthesis, the induction of induced RV myocardial growth. immediate early genes and the re-expression of fetal gene Selective increased expression of PKC-a, PKC-bI and programs [2, 3] . Several growth factors, including PKC-d in PAB-induced RV hypertrophy was observed in endothelin-1 (ET-1), as well as plasma membrane associthe cytosol and to a lesser extent in the membrane fraction. ated mechanosensitive ion channels have been proposed as Whereas acute stimulation of PKC has been reported to be the transduction mechanism between pressure overload and associated with intracellular translocation from the cytosol protein synthesis in cardiomyocyte hypertrophy [23] .
to the particulate fraction [18] , permanent activation of Among intracellular signaling molecules, the calcineurin / PKC might not lead to chronic translocation. Several calmodulin pathway and several protein kinases such as studies provide evidence for a redistribution of activated PKC isozymes from the plasma membrane back to the the PKC inhibitor bisindolylmaleimide (data not shown). cytosol. Huang et al. demonstrated in arachidonic acidThese results implicate an autoregulatory process and treated isolated adult rat cardiomyocytes a transient insuggest that PKC activation might play a role in the crease of activated PKC-´in the membrane fraction within upregulation of PKC isozyme protein expression. 1 min, whereas after 5 min most of the enzyme was found Differential regulation of PKC isozymes has also been in the cytoskeletal filaments and nuclear region, indicating reported in other models of cardiac hypertrophy. We have a re-translocation of activated PKC-´to cytosol compartpreviously shown that banding of the ascending aorta leads ments [29] . In this respect, PKC isozymes have been to an increased expression of PKC-a and PKC-d in LV, shown to play an important role in nuclear signaling with both at the protein and the mRNA level, whereas PKC-t he induction of immediate early response genes (c-fos, remained unchanged [6] . Gaq subunit in the heart of transgenic mice is sufficient to upregulate these and other transcription factors (SRE, induce cardiac hypertrophy, which is accompanied by an Creb), which are known to induce gene expression responupregulation of PKC-a and PKC-d isozymes without sible for myocardial growth [32, 33] . However, the molecuenhanced expression of PKC-´ [35] . Similar results have lar mechanism responsible for the upregulation of distinct been reported by Wettschureck et al., who showed that cytosolic PKC isozymes is not known. In this respect, we cardiomyocyte-specific overexpression of the a -adren- ing pressure-overload myocardial growth [36] . Further apoptosis is not only related to enhanced afterload, but is experiments are necessary to evaluate the impact of Gaq dependent on humoral factors such as activation of the signaling and the influence of G-protein-coupled receptors local / systemic RAS [20, 37] . Long-term administration of in the intracellular signaling pathway leading to PABthe ACE inhibitor enalapril or the AT1 receptor antagonist induced PKC isozyme regulation and RV hypertrophy.
losartan was accompanied by a ''normalization'' of myocardial apoptosis [37] . Only very few studies are available which evaluate myocardial apoptosis in pressure-4 .1. PAB-induced RV apoptosis overload RV hypertrophy. Ikeda et al. reported increased cardiomyocyte apoptosis after experimental banding of the Another salient finding of the preset study was the main pulmonary artery in Sprague-Dawley rats, which occurrence of myocardial apoptosis in PAB-induced RV was accompanied by increased mRNA levels of p53 and hypertrophy, which was demonstrated by an increased Bax protein, both of which are known to be important expression of Bax protein and caspase-3, whereas the effector enzymes in apoptosis [38] . It should be mentioned myocardial expression of Bcl-2 was unchanged compared that the signaling pathway representing the linkage beto sham-operated controls. In contrast to PAB-induced RV tween pressure overload and apoptosis in RV hypertrophy hypertrophy, cardiac apoptosis in RV pressure overload is not known and remains to be evaluated. Several recent was significantly attenuated by chronic treatment with studies have reported a pivotal role of PKC isozymes in ramiprilate.
the signaling cascade of ANG II-induced apoptosis [12, 15] Cardiac apoptosis in response to pressure overload has and the potential role of PKC-d [39] . These data were been reported to occur in LV hypertrophy induced by predominantly obtained from cardiomyocytes isolated from aortic banding or systemic hypertension [14, 15] . Using the left ventricle or the whole heart. However, in the spontaneous hypertensive rats (SHR) Fortuno et al. and present study, the expression pattern of cardiac PKC Diez et al. have shown that SHR-induced cardiomyocyte isozymes in PAB rats was not changed in response to ACE inhibition with ramiprilate, implying that PKC isozyme Bax protein and caspase-3), which could be diminished by upregulation might not play a major role in PAB-induced chronic ACE inhibitor treatment with ramiprilate. RV apoptosis.
A limitation of the present study is that the cell types responsible for the upregulation of the PKC isozymes have A cknowledgements not been characterized. Both PKC-a and PKC-d have been shown to be expressed in neonatal and adult rat carThis study was supported by the Deutsche Forschungsdiomyocytes [2, 5, 12, 24] . Since cardiomyocytes are the gemeinschaft, Bonn, SFB 326. predominant cell type in the heart, it is proposed that those changes in PKC isozyme regulation likely occur in this cell type.
R eferences In summary, PAB-induced RV hypertrophy results in an increased expression of PKC-a, PKC-bI and PKC-d in the PKC-´and PKC-bII was unchanged. This differential 
